Administrative Core

行政核心

基本信息

  • 批准号:
    10334982
  • 负责人:
  • 金额:
    $ 64.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-15 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT – Administrative Core The overarching objective of this COBRE is to promote medical imaging related translational cancer research with a common research theme aiming to improve efficacy of cancer screening, early detection, diagnosis, and treatment through the collaborative efforts between the biomedical engineering researchers and the physician scientists in the University of Oklahoma. In order to support the objective of this COBRE application, the Administrative Core will provide leadership and guidance to ensure the efficient operation and management of all components of the COBRE through effective oversight, fiscal responsibility, and a transparent administrative infrastructure. PD/PI of this COBRE will work closely with the external advisory committee (EAC) and internal advisory committee (IAC) to guide and monitor the progress of the overall operation of the Administrative Core, all research projects and two research resource supporting cores of this COBRE. Specifically, the Administrative Core has multiple essential operation activities including to (1) coordinate the research and mentoring activities, (2) communicate with the oversight committees (i.e. the EAC, IAC and other advisory committees of two research resource supporting cores), (3) assess progress of both the COBRE as a whole and the individual cores, (4) evaluate progress and milestones of the junior research project leaders (RPLs) in their research projects and career development, (5) select and manage the pilot projects to build a sustainable pipeline of the RPLs, (6) identify and recruit new RPLs to replace the RPLs who graduate from the COBRE, (7) organize research seminars and workshops, (8) manage budget of the COBRE and track all financial activities, and (9) monitor all COBRE activities to ensure the compliance with all federal research policies and regulations. The Administrative Core will also include a COBRE Coordinator to assist Core Director in the management of routine fiscal and grant activities of the COBRE, such as helping with scheduling meetings and conference rooms as needed, video and tele-conferencing needs as necessary, securing venues for seminars and workshops, and scheduling travel plans and generating itineraries for the EAC members and the invited speakers. Thus, in order to successfully fulfill the goals or tasks of this Administrative Core, we propose the following three Specific Aims. Aim 1: we will support a well-integrated administrative infrastructure to effectively coordinate mentoring and oversight of the promising RPLs and the pilot project investigators in conducting their research projects and career development. Aim 2: we will establish and implement the selection and evaluation criteria for sustaining the pool of promising junior investigators for RPLs in this COBRE. Aim 3: we will support the research resource supporting cores to help promote and enhance the medical imaging related translational cancer research activities and synergy between the resource supporting cores and research projects.
摘要 – 行政核心 COBRE 的首要目标是促进医学成像相关的转化癌症研究 共同的研究主题旨在提高癌症筛查、早期检测、诊断和治疗的功效 通过生物医学工程研究人员和医生之间的合作努力进行治疗 俄克拉荷马大学的科学家们为了支持这一 COBRE 应用程序的目标, 行政核心将提供领导和指导,确保高效运营和管理 通过有效的监督、财政责任和透明的行政管理,COBRE 的所有组成部分 该 COBRE 的 PD/PI 将与外部咨询委员会 (EAC) 和内部密切合作。 咨询委员会(IAC)指导和监督行政核心整体运作的进展, 该 COBRE 的所有研究项目和两个研究资源支持核心,特别是行政管理。 核心有多项基本运营活动,包括 (1) 协调研究和指导活动, (2) 与两个研究的监督委员会(即EAC、IAC和其他咨询委员会)进行沟通 资源支持核心),(3) 评估 COBRE 整体和各个核心的进展,(4) 评估初级研究项目负责人 (RPL) 在其研究项目中的进展和里程碑, 职业发展,(5) 选择和管理试点项目以建立可持续的 RPL 渠道,(6) 识别并招募新的 RPL 来替代从 COBRE 毕业的 RPL,(7) 组织研究 研讨会和讲习班,(8) 管理 COBRE 的预算并跟踪所有财务活动,以及 (9) 监控所有 COBRE 活动确保遵守所有联邦研究政策和法规。 核心还将包括一名 COBRE 协调员,协助核心总监管理日常财务和财务事务。 COBRE 的资助活动,例如根据需要帮助安排会议和会议室, 必要时满足视频和电话会议需求,确保研讨会和讲习班的场地并安排时间 为 EAC 成员和受邀演讲者制定旅行计划并制定行程。 为成功完成本行政核心的目标或任务,我们提出以下三个具体目标。 目标 1:我们将支持完善的行政基础设施,以有效协调指导和 对有前景的 RPL 和试点项目研究者进行研究项目进行监督 目标2:建立并实施可持续发展的选择和评估标准。 目标 3:我们将支持研究资源。 支持核心,帮助促进和加强医学影像相关的转化癌症研究 资源支持核心和研究项目之间的活动和协同作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bin Zheng其他文献

Bin Zheng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bin Zheng', 18)}}的其他基金

Oklahoma Center of Medical Imaging for Translational Cancer Research
俄克拉荷马州转化癌症研究医学影像中心
  • 批准号:
    10334981
  • 财政年份:
    2022
  • 资助金额:
    $ 64.25万
  • 项目类别:
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization
粘连蛋白复合物 STAG2 通过 3D 基因组组织调节黑色素瘤中的干扰素信号传导
  • 批准号:
    10905899
  • 财政年份:
    2022
  • 资助金额:
    $ 64.25万
  • 项目类别:
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
  • 批准号:
    9690391
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:
Mammographic Density and Tissue Asymmetry Based Breast Cancer Risk Stratification
基于乳房 X 光密度和组织不对称性的乳腺癌风险分层
  • 批准号:
    8691598
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
  • 批准号:
    8723596
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:
Targeting the LKB1-AMPK PATHWAY in Melanoma: Mechanism and Preclinical Evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
  • 批准号:
    8466942
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:
Mammographic Density and Tissue Asymmetry Based Breast Cancer Risk Stratification
基于乳房 X 光密度和组织不对称性的乳腺癌风险分层
  • 批准号:
    8826571
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:
Targeting the LKB1-AMPK PATHWAY in Melanoma: Mechanism and Preclinical Evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
  • 批准号:
    8275994
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
  • 批准号:
    8657935
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:
Mammographic Density and Tissue Asymmetry Based Breast Cancer Risk Stratification
基于乳房 X 光密度和组织不对称性的乳腺癌风险分层
  • 批准号:
    8282037
  • 财政年份:
    2012
  • 资助金额:
    $ 64.25万
  • 项目类别:

相似海外基金

Otolaryngology Clinician-Scientist Training Program
耳鼻喉科临床医生科学家培训计划
  • 批准号:
    10649406
  • 财政年份:
    2022
  • 资助金额:
    $ 64.25万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10573267
  • 财政年份:
    2022
  • 资助金额:
    $ 64.25万
  • 项目类别:
Otolaryngology Clinician-Scientist Training Program
耳鼻喉科临床医生科学家培训计划
  • 批准号:
    10291583
  • 财政年份:
    2022
  • 资助金额:
    $ 64.25万
  • 项目类别:
2022 Aspen/Snowmass Perinatal Biology Conference
2022 年阿斯彭/斯诺马斯围产期生物学会议
  • 批准号:
    10539556
  • 财政年份:
    2022
  • 资助金额:
    $ 64.25万
  • 项目类别:
Cardiovascular Outcomes Research in Perioperative Medicine - COR-PM
围手术期医学心血管结局研究 - COR-PM
  • 批准号:
    10392118
  • 财政年份:
    2021
  • 资助金额:
    $ 64.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了